Synthon appoints Rudy Mareel as CEO
Synthon, 03/09/2010
Free full text
Synthon is pleased to announce that Rudy Mareel has joined the Company as CEO. Mr. Mareel will focus on extending Synthon’s commercial success in the generics business and opening up new avenues for growth. Dr. Jacques Lemmens, Synthon’s founder, will continue to play a key leadership role within the company, providing long–term strategic direction and guidance for critical R&D activities in particular. Mareel and Lemmens form a strong and complimentary executive partnership to take Synthon to a new level of influence in the generics and speciality pharma sector.







